ALPMY Stock Price Chart
ALPMY Stock Price Prediction
Astellas Pharma Inc.
$0
0%
$0
As of today:Jul 14, 14:39:02 GMT-4
Back
Astellas Pharma Inc. (ALPMY) Stock Price Prediction
Key Stats
Prev.Close
--
Open
--
Day's Range
-
52 week range
-
Volume
--
Avg.Volume
188.9K
Dividend yield
--
EPS (TTM)
1.00
Market Cap
--
What is Astellas Pharma, Inc.?
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 13,643 full-time employees. The firm mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.
